Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis

Summary

The purpose of this study is to evaluate the therapeutic efficacy and safety of DSXS compared to a Placebo (vehicle) in patients with mild to moderate plaque psoriasis.

Timeline

Start

2015-08-28

Primary completion

2017-03-16

Completion

2017-08-25

Outcome

Missed primary endpoint

registry analysis (superiority test); DSXS1505 vs Placebo; p = 0.0745; Cochran-Mantel-Haenszel NCT02618759 ↗

registry analysis (superiority test); DSXS1505 vs Placebo; p = 0.2310; Cochran-Mantel-Haenszel NCT02618759 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	DSXS	Unknown	0.15 %	Topical

Indications